Byakangelicol
Byakangelicol is a research compound with potential to inhibit P-glycoprotein at the blood-brain barrier in vivo. It also demonstrates anti-inflammatory properties by suppressing COX-2 expression and activity, reducing PGE2 release in cellular models like A549 cells, indicating relevance for neuropharmacology and airway inflammation research.
Product Specifications
CAS Number
26091-79-2
Product Name Alternative
Byakangelicol, Cyclooxygenase, COX, COX-2, inhibit, Inhibitor
Field of Research
Immunology & Inflammation, Neuroscience
Purity
98.78% (May vary between batches)
Solubility
DMSO:55 mg/mL (173.88 mM) ; Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.:Soluble
Smiles
[H][C@]1 (COc2c3occc3c (OC) c3ccc (=O) oc23) OC1 (C) C
Molecular Formula
C17H16O6
Molecular Weight
316.31
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15218001 1 Vial
Lentiviral mouse Tmem97 shRNA (UAS) - Lentiviral mouse Tmem97 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details 
251354-ML750 100 µL
RXRA (Retinoid X Receptor, alpha, FLJ00280, FLJ00318, FLJ16020, FLJ16733, MGC102720, NR2B1) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
